Study of 90 Still’s Dz pts w/ lung disease from AIDA network – mean age 36 yr; 36% male (13% from pediatrics). Lung find
Study of 90 Still’s Dz pts w/ lung disease from AIDA network – mean age 36 yr; 36% male (13% […]
RheumNow
RheumNow
RheumNow
It’s now called Sjögren Disease! Sjögren syndrome is now Sjögren disease, according to recommendations stemming fro
It’s now called Sjögren Disease! Sjögren syndrome is now Sjögren disease, according to recommendations stemming fro https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 08/25/2025
RheumNow
Biologics and Biosimilars Global Market size was valued at~ $478.83 Billion USD in 2024; expected to reach $527.36 Billi
Biologics and Biosimilars Global Market size was valued at~ $478.83 Billion USD in 2024; expected to reach $527.36 Billi https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
AbbVie announces positive topline results from a 2nd Phase 3 UP-AA Trial evaluating Upadacitinib in Alopecia Areata (AA)
AbbVie announces positive topline results from a 2nd Phase 3 UP-AA Trial evaluating Upadacitinib in Alopecia Areata (AA) https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
https://t.co/nk6sBThX0v
https://t.co/nk6sBThX0v https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 08/24/2025 – 10:00 RheumNow Dr. John Cush https://t.co/nk6sBThX0v 24-08-2025 https://pbs.twimg.com/media/GzH1Cv1WYAAUAfA.jpg
RheumNow
FDA has granted Soligenix “Orphan Drug Designation” to study dusquetide in the treatment of Behçet’s dz, based on an 8
FDA has granted Soligenix “Orphan Drug Designation” to study dusquetide in the treatment of Behçet’s dz, based on an 8
RheumNow
Single-center Retrospective study of 4,736 RA, propensity matched 509 w/ RA-ILD vs 509 without ILD. In multivariate ana
Single-center Retrospective study of 4,736 RA, propensity matched 509 w/ RA-ILD vs 509 without ILD. In multivariate ana https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Telitacicept, a BLyS (BAFF)/APRIL dual-target fusion drug, announced it has met the primary endpoint in its Phase III cl
Telitacicept, a BLyS (BAFF)/APRIL dual-target fusion drug, announced it has met the primary endpoint in its Phase III cl https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Prenatal acetaminophen linked to increased autism and ADHD
Prenatal acetaminophen linked to increased autism and ADHD jjcush@gmail.com Fri, 08/22/2025 – 13:45
RheumNow
TriNetX database study shows Beta blocker use assoc w/ more hip replacements (THA). 23K propensity matched pts (mean age
TriNetX database study shows Beta blocker use assoc w/ more hip replacements (THA). 23K propensity matched pts (mean age https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Rapid rituximab infusions are safe & efficient. Metanalysis of 7 RCTs, 538 pts w/ autoimmune/rheumatic dz, showed i
Rapid rituximab infusions are safe & efficient. Metanalysis of 7 RCTs, 538 pts w/ autoimmune/rheumatic dz, showed i https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
New IDSA recommendation: In hospitalized on systemic steroids w/ severe, critical, progressing COVID-19, when baricitini
New IDSA recommendation: In hospitalized on systemic steroids w/ severe, critical, progressing COVID-19, when baricitini https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 08/22/2025 –
RheumNow
Sjogrens Graduates (8.22.2025)
Sjogrens Graduates (8.22.2025) jjcush@gmail.com Fri, 08/22/2025 – 07:58
RheumNow
ChildCAPTURE & BioCAPTURE registry studies of 117 pediatric & 243 young adult Psoriasis pts on biologics (753.4
ChildCAPTURE & BioCAPTURE registry studies of 117 pediatric & 243 young adult Psoriasis pts on biologics (753.4 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
RheumNow
It’s now called Sjögren Disease!
It’s now called Sjögren Disease! jjcush@gmail.com Thu, 08/21/2025 – 17:48
RheumNow
It’s now called Sjogrens Disease!
It’s now called Sjogrens Disease! jjcush@gmail.com Thu, 08/21/2025 – 17:48
RheumNow
Antibiotics are not linked to Autoimmune disease in kids
Antibiotics are not linked to Autoimmune disease in kids jjcush@gmail.com Thu, 08/21/2025 – 16:50
RheumNow
Safety of Combination Targeted Therapies in Psoriatic Arthritis Treating psoriatic arthritis (PsA) patients with more t
Safety of Combination Targeted Therapies in Psoriatic Arthritis Treating psoriatic arthritis (PsA) patients with more t https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 08/21/2025
RheumNow
Rheums Speak: Future of Rheumatoid Arthritis The third survey in this series addressed clinician views on future trends
Rheums Speak: Future of Rheumatoid Arthritis The third survey in this series addressed clinician views on future trends https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Uncertainty with immunosuppressive for idiopathic inflammatory myopathies A current Cochrane review suggests a continu
Uncertainty with immunosuppressive for idiopathic inflammatory myopathies A current Cochrane review suggests a continu https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 08/21/2025 – 16:28
RheumNow
Claims data study of 82 399 PsA pts – 542 on combo targeted Rx >3 mos (200 > 6mos). 2 most common combos of apre
Claims data study of 82 399 PsA pts – 542 on combo targeted Rx >3 mos (200 > 6mos). 2 most
RheumNow
RCT of 2331 chronic MSK pain pts showed that telehealth Cognitive behavioral therapy (CBT) (health coach) superior to se
RCT of 2331 chronic MSK pain pts showed that telehealth Cognitive behavioral therapy (CBT) (health coach) superior to se https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Cardiovascular Sequelae in Adults After Kawasaki Disease
Cardiovascular Sequelae in Adults After Kawasaki Disease jjcush@gmail.com Wed, 08/20/2025 – 17:25
RheumNow
Safety of Combination Targeted Therapies in Psoriatic Arthritis
Safety of Combination Targeted Therapies in Psoriatic Arthritis jjcush@gmail.com Wed, 08/20/2025 – 16:47
RheumNow
The global autoimmune disease treatment market was valued at $7 billion USD in 2024 and is expected to rise to ~$11 bill
The global autoimmune disease treatment market was valued at $7 billion USD in 2024 and is expected to rise to
RheumNow
Clinical Rheumatology Thread for Busy GPs: Post 1 Early inflammatory arthritis(IA): the 3–3–3 rule •Onset ≤3 mon
Clinical Rheumatology Thread for Busy GPs: Post 1 Early inflammatory arthritis(IA): the 3–3–3 rule •Onset ≤3 mon https://pbs.twimg.com/profile_images/1877043944435101699/szzH4558_normal.jpg john+RNV2@john… Wed,
RheumNow
Gout Education Card for Patients – Info & Rules #1 https://t.co/uppST8OBLZ https://t.co/3Ry3erNJCL
Gout Education Card for Patients – Info & Rules #1 https://t.co/uppST8OBLZ https://t.co/3Ry3erNJCL https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 08/20/2025 – 16:20 RheumNow Dr.